1 min read
Add as a preferred source on Google

Ascend Wellness Projects Approximately 1% to 2% Q4 Revenue Growth

The company had 61 stores after the third quarter and plans to bring two product lines to Canadian shelves in Q1 2027.

An unbranded dispensary counter sits before rows of display cases. / TokenPost.ai
An unbranded dispensary counter sits before rows of display cases. / TokenPost.ai

Ascend Wellness Holdings, Inc. expects fourth-quarter 2026 revenue to rise approximately 1% to 2%, while expanding its retail network and preparing a first-quarter 2027 launch in Canada.

Third-quarter revenue was $130 million, up 3.1% from the previous quarter and 4.2% from the year-earlier period. The company returned to year-over-year growth as price compression continued.

Ascend's adjusted EBITDA margin was 23.9% in the third quarter. Management expects a similar margin in the fourth quarter, with seasonal discounts and pricing pressure as offsets.

The company reached 60 stores ahead of schedule and had 61 open after the third quarter ended.

Under a licensing agreement, High Wired Infused Pre-Rolls and Ozone Liquid Diamond Vapes are expected to reach Canadian shelves in the first quarter of 2027. Management described the rollout as an initial test of the brands' appeal in international markets.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…